# Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

> **NCT04383119** · PHASE2 · RECRUITING · sponsor: **Italian Sarcoma Group** · enrollment: 100 (estimated)

## Conditions studied

- Leiomyosarcoma of Ovary
- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Trabectedin
- **DRUG:** Gemcitabine
- **DRUG:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT04383119
- **Lead sponsor:** Italian Sarcoma Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-29
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04383119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04383119, "Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04383119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*